Norgesic (Orphenadrine Citrate, Paracetamol)

Orphenadrine citrate acts as a centrally acting anticholinergic muscle relaxant. By blocking muscarinic receptors in the central nervous system, it reduces neuronal excitability, leading to decreased muscle tone and relief of spasm.

The appropriate dose of Norgesic is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Norgesic in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their doctor.

To order Norgesic, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with agents such as cyclobenzaprine, Norgesic adds paracetamol, offering both muscle relaxation and analgesia in a single tablet. This can simplify regimens but may increase the risk of hepatotoxicity, especially when combined with other paracetamol‑containing products.

Store Norgesic at ambient temperature, preferably below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Norgesic is taken orally, usually with a full glass of water. It should be swallowed whole and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, liver injury (hepatotoxicity), and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience rash, jaundice, difficulty breathing, or swelling.

Norgesic should be avoided in individuals with known hypersensitivity to orphenadrine, paracetamol, or any excipients, as well as in patients with severe liver disease, uncontrolled glaucoma, or those taking MAO inhibitors. Consultation with a healthcare provider is essential before starting therapy.